Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation crawled time : 23:00 save search
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $1.87 -10.95% -12.3% 1.4M
|
Health Technology
|
| O: 2.56%
H: 2.0%
C: 0.0%
adi-270 presentation cell preclinical for meeting therapy
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
SPRB | News | $0.705 0.54% 0.54% 420K
|
Health Technology
|
| O: -2.86%
H: 2.94%
C: 1.47%
presentation endocrine meeting
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Published: 2024-04-17 (Crawled : 23:00) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K
|
| Email alert
Add to watchlist
presentation meeting
MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)
Published: 2024-04-02 (Crawled : 23:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: 2.01%
H: 4.61%
C: 0.0%
mn-166 presentation meeting trial results glioblastoma
MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
Published: 2024-03-20 (Crawled : 23:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: 2.7%
H: 2.67%
C: 0.2%
mn-001 presentation meeting
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 23:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.21%
H: 5.61%
C: 3.95%
association presentation cancer research meeting therapeutics
REVALESIO ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 RESCUE STUDY OF RNS60 IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN LATE-BREAKING ORAL PRESENTATION AT ISC 2024
Published: 2024-02-07 (Crawled : 23:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
rns60 stroke presentation positive topline study
Greenbrier to webcast presentation at the Stifel 2024 Transportation & Logistics Conference
Published: 2024-02-06 (Crawled : 23:00) - prnewswire.com
GBX S | $53.49 0.95% 280K
|
Producer Manufacturing
|
| O: 0.0%
H: 0.94%
C: 0.9%
conference presentation
Navigator Gas to Present at Capital Link’s Corporate Presentation Series
Published: 2024-01-29 (Crawled : 23:00) - globenewswire.com
NVGS | $14.91 -0.67% 0.0% 290K
|
Transportation
|
| O: -0.12%
H: 1.24%
C: 0.81%
presentation gas series
Luvelta Forum – Presentation
Published: 2024-01-04 (Crawled : 23:00) - sutrobio.com
STRO | $3.47 -6.72% -7.2% 540K
|
Health Technology
|
| O: -4.28%
H: 0.0%
C: -17.88%
presentation
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology
Published: 2023-12-21 (Crawled : 23:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: -2.67%
mn-166 lung presentation meeting
Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting
Published: 2023-12-11 (Crawled : 23:00) - prnewswire.com
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: -7.45%
nktr-255 presentation preclinical meeting
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
Published: 2023-11-15 (Crawled : 23:00) - alteritytherapeutics.com
ATHE | $2.33 9.39% 8.58% 170K
|
Health Technology
|
| O: -2.0%
H: 0.56%
C: -2.08%
ath434 presentation therapeutics
Immuron CEO Steven Lydeamore Investor Webinar Presentation
Published: 2023-11-13 (Crawled : 23:00) - globenewswire.com
IMRN | $2.46 4.94% 1.3K
|
Health Technology
|
| O: 4.12%
H: 6.78%
C: 6.78%
ceo presentation
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
Published: 2023-10-17 (Crawled : 23:00) - biospace.com/
SONN | $1.78 5.83% 6.2K
|
Health Technology
|
| O: 0.0%
H: 8.82%
C: 4.62%
presentation meeting
Pyros Pharmaceuticals’ Abstract Accepted for Poster Presentation at the American Epilepsy Society (AES) 2023 Annual Meeting
Published: 2023-10-10 (Crawled : 23:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
presentation meeting
Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation
Published: 2023-09-25 (Crawled : 23:00) - globenewswire.com
NVCT | $6.715 1.9% 1.86% 51K
|
|
| O: -2.84%
H: 6.08%
C: 2.63%
pharma conference presentation global
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the Annual Meeting of the Society for Neuro-Oncology
Published: 2023-08-17 (Crawled : 23:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: -1.14%
H: 3.95%
C: 1.32%
mn-166 presentation meeting glioblastoma
Aravive Announces Poster Presentation on Batiraxcept at 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 23:00) - biospace.com/
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: -4.97%
presentation asco meeting
Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Published: 2023-04-26 (Crawled : 23:00) - biospace.com/
TCRT 4 | $1.17 -2.5% -2.56% 30K
|
Manufacturing
|
| O: -3.1%
H: 14.05%
C: 9.98%
presentation meeting therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.